This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Major Depression or Fibromyalgia
and you are
between 18 and 80
years old
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Depression and unrefreshed sleep are frequent in patients with fibromyalgia. Agomelatine is a new antidepressant with sleep-promoting properties. The objective of this study include the assessment of agomelatine therapy in patients with depression and fibromyalgia both on the severity of depressive symptomatology and sleep quality.

Provided treatments

  • Drug: agomelatine
Tris trial is registered with FDA with number: NCT01731899. The sponsor of the trial is Universidad de Granada and it is looking for 27 volunteers for the current phase.
Official trial title:
Observational Study Evaluating the Efficacy and Tolerability of Agomelatine in the Treatment of Depressed Patients With Fibromyalgia